New treatment prevents deadly infections in cystic fibrosis patients

A new treatment that can completely kill off an infection that can be deadly to those with cystic fibrosis has been found thanks to collaboration between researchers at Aston University and BHP founder members Birmingham Children’s Hospital. The findings of the project, led by scientists at the university’s Mycobacterial Research Group, showed combined doses of … Continue reading “New treatment prevents deadly infections in cystic fibrosis patients”

Birmingham named one of just six new Life Sciences Opportunity Zones

The Birmingham Health Partners ecosystem – which will soon begin construction of Birmingham Life Sciences Park – has been awarded Life Sciences Opportunity Zone status by the Department for Business, Energy and Industrial Strategy (BEIS). As one of only six sites in the country to receive this designation, Birmingham Health Partners (BHP) has been recognised … Continue reading “Birmingham named one of just six new Life Sciences Opportunity Zones”

Domestic abuse survivors ‘44% more likely to die’ than peers

Women who have experienced domestic abuse appear to be more than 40 per cent more likely to die from any cause compared to the general population, a study led by the University of Warwick and BHP founder member the University of Birmingham suggests. The researchers have also identified an increased risk of developing cardiometabolic diseases such … Continue reading “Domestic abuse survivors ‘44% more likely to die’ than peers”

The trauma landscape – #WhyWeDoResearch

The face of trauma and emergency medicine is undeniably changing. Between 2008 and 2017, there were almost 250,000 major trauma cases in the NHS – and the complexity of cases has increased for a number of reasons: > Patients are getting older. In 2008, the median age of trauma patients was 45. By 2017, it … Continue reading “The trauma landscape – #WhyWeDoResearch”

Personalisation could improve bile duct cancer treatments

Treatment of patients suffering from bile duct cancer could be improved by tailoring medication to the levels of a key protein in people with the disease, according to new research. Cholangiocarcinoma (CCA) is a deadly disease with few treatments, but researchers in the UK and Thailand have discovered that the PRH/HHEX protein is a key … Continue reading “Personalisation could improve bile duct cancer treatments”